Modeling the Effect of HIV/AIDS Stigma on HIV Infection Dynamics in Kenya.


Journal

Bulletin of mathematical biology
ISSN: 1522-9602
Titre abrégé: Bull Math Biol
Pays: United States
ID NLM: 0401404

Informations de publication

Date de publication:
05 04 2021
Historique:
received: 30 09 2020
accepted: 15 03 2021
entrez: 5 4 2021
pubmed: 6 4 2021
medline: 29 10 2021
Statut: epublish

Résumé

Stigma toward people living with HIV/AIDS (PLWHA) has impeded the response to the disease across the world. Widespread stigma leads to poor adherence of preventative measures while also causing PLWHA to avoid testing and care, delaying important treatment. Stigma is clearly a hugely complex construct. However, it can be broken down into components which include internalized stigma (how people with the trait feel about themselves) and enacted stigma (how a community reacts to an individual with the trait). Levels of HIV/AIDS-related stigma are particularly high in sub-Saharan Africa, which contributed to a surge in cases in Kenya during the late twentieth century. Since the early twenty-first century, the United Nations and governments around the world have worked to eliminate stigma from society and resulting public health education campaigns have improved the perception of PLWHA over time, but HIV/AIDS remains a significant problem, particularly in Kenya. We take a data-driven approach to create a time-dependent stigma function that captures both the level of internalized and enacted stigma in the population. We embed this within a compartmental model for HIV dynamics. Since 2000, the population in Kenya has been growing almost exponentially and so we rescale our model system to create a coupled system for HIV prevalence and fraction of individuals that are infected that seek treatment. This allows us to estimate model parameters from published data. We use the model to explore a range of scenarios in which either internalized or enacted stigma levels vary from those predicted by the data. This analysis allows us to understand the potential impact of different public health interventions on key HIV metrics such as prevalence and disease-related death and to see how close Kenya will get to achieving UN goals for these HIV and stigma metrics by 2030.

Identifiants

pubmed: 33818710
doi: 10.1007/s11538-021-00891-7
pii: 10.1007/s11538-021-00891-7
pmc: PMC8021528
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

55

Commentaires et corrections

Type : ErratumIn

Références

Soc Sci Med. 2010 Feb;70(3):368-374
pubmed: 19892454
Int J STD AIDS. 2019 Mar;30(4):362-370
pubmed: 30501366
Lancet. 2013 Nov 2;382(9903):1515-24
pubmed: 24152938
AIDS Behav. 2013 Jun;17(5):1796-808
pubmed: 23479002
AIDS Behav. 2017 Sep;21(9):2579-2588
pubmed: 28058565
J Int AIDS Soc. 2016 Dec 12;19(1):21134
pubmed: 27964776
Lancet. 2009 Jan 3;373(9657):48-57
pubmed: 19038438
J Theor Biol. 2019 Sep 7;476:95-107
pubmed: 31153888
J Acquir Immune Defic Syndr. 2017 May 1;75(1):e22-e23
pubmed: 28225436
BMC Pregnancy Childbirth. 2017 Mar 21;17(1):94
pubmed: 28320347
J Health Commun. 2006 Dec;11(8):755-67
pubmed: 17190781
Psychol Health Med. 2006 Aug;11(3):307-34
pubmed: 17130068
AIDS Behav. 2013 Sep;17(7):2474-8
pubmed: 23117574
AIDS. 2017 Apr 24;31(7):995-1007
pubmed: 28121707
N Engl J Med. 2008 Nov 20;359(21):2233-44
pubmed: 19020325
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
J Behav Med. 2019 Jun;42(3):534-544
pubmed: 30600404
AIDS Care. 2010;22 Suppl 2:1569-79
pubmed: 21161761
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):399-407
pubmed: 28406807
AIDS Care. 2014;26(11):1419-25
pubmed: 24921155
Soc Sci Med. 2003 Jul;57(1):13-24
pubmed: 12753813
AIDS Behav. 2011 Aug;15(6):1140-52
pubmed: 21082339
AIDS Care. 2017 Nov;29(11):1364-1372
pubmed: 28325068
J Theor Biol. 2008 Sep 7;254(1):178-96
pubmed: 18572196
PLoS One. 2017 Dec 8;12(12):e0189079
pubmed: 29220369
PLoS One. 2016 Sep 26;11(9):e0162826
pubmed: 27669510
AIDS Behav. 2013 Oct;17(8):2597-603
pubmed: 23525789
AIDS Patient Care STDS. 2013 Nov;27(11):621-7
pubmed: 24138486
J Acquir Immune Defic Syndr. 2015 May 1;69 Suppl 1:S16-24
pubmed: 25867774
J Int AIDS Soc. 2014 Sep 08;17:19052
pubmed: 25204872
Trop Med Int Health. 2012 Aug;17(8):e66-73
pubmed: 22943381
AIDS Behav. 2009 Dec;13(6):1160-77
pubmed: 19636699
J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):558-64
pubmed: 27035888
Math Biosci Eng. 2008 Oct;5(4):757-70
pubmed: 19278280
AIDS Care. 2014 Feb;26(2):206-13
pubmed: 23795954
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640
pubmed: 24242258
Math Biosci. 2003 Jan;181(1):17-54
pubmed: 12421551
Glob Public Health. 2011;6(1):83-97
pubmed: 20509066
JAMA. 2006 Aug 9;296(6):679-90
pubmed: 16896111

Auteurs

Ben Levy (B)

Department of Mathematics, Fitchburg State University, Fitchburg, MA, USA.

Hannah E Correia (HE)

Harvard Data Science Initiative, Harvard University, Cambridge, MA, USA.
Department of Biostatistics, Harvard University, Boston, MA, USA.

Faraimunashe Chirove (F)

Department of Mathematics and Applied Mathematics, University of Johannesburg, Johannesburg, South Africa.

Marilyn Ronoh (M)

School of Mathematics, University of Nairobi, Nairobi, Kenya.

Ash Abebe (A)

Department of Mathematics and Applied Mathematics, University of Johannesburg, Johannesburg, South Africa.

Moatlhodi Kgosimore (M)

Department of Biometry and Mathematics, Botswana University of Agriculture and Natural Resources, Gaborone, Botswana.

Obias Chimbola (O)

Mathematics and Statistical Sciences, Botswana International University of Science and Technology, Palapye, Botswana.

M Hellen Machingauta (MH)

Mathematics and Statistical Sciences, Botswana International University of Science and Technology, Palapye, Botswana.

Suzanne Lenhart (S)

Mathematics Department, University of Tennessee, Knoxville, TN, USA.

K A Jane White (KAJ)

Department of Mathematical Sciences, University of Bath, Bath, UK. maskajw@bath.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH